Pre-made Latozinemab benchmark antibody ( Whole mAb, anti-SORT1 therapeutic antibody, Anti-Gp95/LDLCQ6/NT3/NTR3 Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-298

Pre-Made Latozinemab biosimilar, Whole mAb, Anti-SORT1 Antibody: Anti-Gp95/LDLCQ6/NT3/NTR3 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Action and use: Molecular formula, Chemical Abstracts Service (CAS) registry number: Graphic formula.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-298-1mg 1mg 3090 30% 2163

Size： 1mg | 10mg | 100mg

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Latozinemab biosimilar, Whole mAb, Anti-SORT1 Antibody: Anti-Gp95/LDLCQ6/NT3/NTR3 therapeutic antibody
INN Name Latozinemab
TargetSORT1
FormatWhole mAb
Derivation
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-III
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2020
Year Recommendedna
CompaniesAlector
Conditions Approvedna
Conditions ActiveFrontotemporal dementia
Conditions Discontinuedna
Development Techna